文献速递脑血管病外科神经重症

日本全国数据库:动脉瘤性蛛网膜下腔出血按年龄与治疗方式的风险管理

Risk Management of Aneurysmal Subarachnoid Hemorrhage by Age and Treatment Method from a Nationwide Database in Japan.
PubMed 文献 · World Neurosurg · 2019-09-12

本研究基于日本2010至2015年全国数据库,比较非老年(<65岁)与老年(≥65岁)动脉瘤性蛛网膜下腔出血患者接受手术夹闭或血管内栓塞后的风险因素。多因素logistic回归显示,各组的不良结局风险因素包括高龄、男性、入院神经功能分级、糖尿病和抗凝药使用;而高容量医院、学术医院、高血压和抗血小板药使用为反向风险因素。老年栓塞患者使用他汀及前交通动脉以外位置亦为反向风险。

要点

  • 高容量医院和学术医院治疗与较低不良结局风险相关。
  • 抗血小板药使用为反向风险因素,抗凝药使用为风险因素。
  • 老年栓塞患者使用他汀可能获益,前交通动脉瘤需更谨慎处理。

核心结论

  • 推荐在高容量和学术机构中管理动脉瘤性蛛网膜下腔出血患者,并给予抗血小板药物并考虑多种风险因素。
  • 老年血管内栓塞患者可能更适合给予他汀药物,慢性心力衰竭或前交通动脉瘤患者应更谨慎治疗。

研究设计与样本

  • 基于日本2010至2015年全国数据库的回顾性队列研究,比较非老年(<65岁)与老年(≥65岁)接受手术夹闭或血管内栓塞的患者。
  • 采用多因素logistic回归分析计算各风险因素对出院时改良Rankin量表评分>2的不良结局的比值比(OR)和95%置信区间(CI)。

主要发现

  • 所有组中不良结局的风险因素为高龄、男性、入院神经功能分级、糖尿病和抗凝药物使用。
  • 反向风险因素为高容量医院、学术医院、高血压和抗血小板药物使用(OR 0.63-0.81;95% CI 0.56-0.88)。
  • 慢性心脏病也是风险因素,但在他汀药物使用(OR 0.85-0.87;95% CI 0.76-0.97)和前交通动脉以外位置(OR 0.74-0.80;95% CI 0.67-0.91)在老年组和血管内栓塞组中为反向风险。

临床怎么用

  • 临床管理动脉瘤性蛛网膜下腔出血时,应优先考虑高容量和学术医院,并评估抗血小板药物使用及多种风险因素。
  • 对老年血管内栓塞患者可考虑他汀治疗,对慢性心力衰竭或前交通动脉瘤患者应加强谨慎处理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: There has been no precise guide for treatment management of aneurysmal subarachnoid hemorrhage (aSAH) based on the patient's age and treatment method. This study clarifies each risk management for aSAH according to age and treatment method listed in a nationwide database. METHODS: We compared 2 groups of patients (nonelderly, <65 years; elderly, ≥65 years) who underwent surgical clipping or endovascular coiling and were registered in a nationwide database in Japan from 2010 to 2015. The odds ratio (OR) and 95% confidence interval (CI) of each risk factor were calculated through multivariate logistic regression analysis for poor outcome according to a modified Rankin Scale score >2 at discharge for each group. RESULTS: In all groups, the risk factors for poor outcome were older age, male sex, neurologic grade on admission, diabetes mellitus, and use of anticoagulation drugs. Inverse risk factors were a high-volume hospital, academic hospital, hypertension, and use of an antiplatelet drug (OR, 0.63-0.81; 95% CI, 0.56-0.88). Chronic heart disease was also a risk factor, but use of a statin drug (OR, 0.85-0.87; 95% CI, 0.76-0.97) and location other than on the anterior communicating artery (OR, 0.74-0.80; 95% CI, 0.67-0.91) were inverse risks in both the elderly and the endovascular coiling groups. CONCLUSIONS: Management for patients with aneurysmal subarachnoid hemorrhage was recommended in high-volume and academic institutes with the administration of antiplatelet drugs and consideration of several risk factors. Elderly patients undergoing endovascular coiling might be better given a statin drug, and patients with chronic heart failure or an anterior communicating artery aneurysm should be treated more carefully.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ikawa F, Michihata N, Iihara K, et al. Risk Management of Aneurysmal Subarachnoid Hemorrhage by Age and Treatment Method from a Nationwide Database in Japan. World Neurosurg. 2019. PMID: 31521760. doi:10.1016/j.wneu.2019.09.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。